Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection

According to the World Health Organization, approximately 150 million people worldwide are chronic carriers of hepatitis C virus (HCV). HCV infection can evolve into cirrhosis of the liver and its complications, which are ultimately responsible for more than 350,000 deaths every year. Antiviral ther...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gentile, Ivan, Buonomo, Antonio Riccardo, Zappulo, Emanuela, Minei, Giuseppina, Morisco, Filomena, Borrelli, Francesco, Coppola, Nicola, Borgia, Guglielmo
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2014
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4079632/
https://ncbi.nlm.nih.gov/pubmed/25061308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S66731
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars